Alpha invests in Solace
We’re excited to announce our investment in Solace's $130 million Series C alongside lead investor IVP, in a round that values the company at over $1 billion. Solace is a technology-enabled healthcare platform that provides personalized patient advocacy services across all 50 states. With over 70 million Americans on Medicare and rising complexity, patients often struggle to navigate fragmented providers, insurance, and treatment plans. Solace addresses this challenge by combining professional healthcare advocates with purpose-built technology to help patients coordinate care, manage chronic conditions, and resolve administrative hurdles. Read more →